EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: EndoTAG-1 + paclitaxel|DRUG: EndoTAG-1|DRUG: Paclitaxel
Sponsor: MediGene